SHINYA YAMAMOTO to Antibodies, Viral
This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Antibodies, Viral.
Connection Strength
0.183
-
CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4+ T cells. Biochem Biophys Res Commun. 2023 12 17; 686:149143.
Score: 0.032
-
Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination. Virol J. 2023 07 13; 20(1):146.
Score: 0.031
-
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1. Lancet Infect Dis. 2023 05; 23(5):525-526.
Score: 0.031
-
Immunological Correlates of Prevention of the Onset of Seasonal H3N2 Influenza. J Infect Dis. 2022 11 11; 226(10):1800-1808.
Score: 0.030
-
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant. Sci Transl Med. 2022 08 10; 14(657):eabm4908.
Score: 0.030
-
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2. Nature. 2022 07; 607(7917):119-127.
Score: 0.029